These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23933759)

  • 1. High-dose melphalan produces favorable response in a patient with multiple myeloma and coexisting essential thrombocythemia with JAK2 mutation.
    Nishihori T; Hassoun Y; Zhang L; Shain K; Alsina M; Kharfan-Dabaja MA
    Bone Marrow Transplant; 2014 Jan; 49(1):148-9. PubMed ID: 23933759
    [No Abstract]   [Full Text] [Related]  

  • 2. Multiple myeloma with concomitant JAK2-positive essential thrombocythemia post-successful autologous peripheral blood hematopoietic stem cell transplant.
    Holtan SG; Hoyer JD; Buadi FK
    Bone Marrow Transplant; 2011 Apr; 46(4):615. PubMed ID: 20581888
    [No Abstract]   [Full Text] [Related]  

  • 3. Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplant.
    Radujkovic A; Hundemer M; Eisenbach C; Luft T; Penzel R; Goldschmidt H; Ho AD; Bellos F
    Leuk Lymphoma; 2014 Dec; 55(12):2967-9. PubMed ID: 24707945
    [No Abstract]   [Full Text] [Related]  

  • 4. Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.
    Au WY; Fung A; Lam KY; Lie AK; Liang R; Kwong YL
    Bone Marrow Transplant; 2006 Oct; 38(8):573-4. PubMed ID: 16953212
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of femoral fracture in a patient with essential thrombocythemia treated with plateletpheresis and intramedullary rod fixation, followed by hydroxyurea: a case report.
    Edlich RF; Long WB; Cochran AA; Kelley AR; Woode DR; Greene JA; Takahashi GW
    Am J Emerg Med; 2008 Jun; 26(5):636.e1-3. PubMed ID: 18534315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential differences in clinical and bone marrow features in BCR/ABL-positive thrombocythemia compared to thrombocythemia in the BCR/ABL-negative myeloproliferative neoplasms essential thrombocythemia and polycythemia vera.
    Michiels JJ; Pich A; De Raeve H; Gadisseur A
    Acta Haematol; 2015; 133(1):52-5. PubMed ID: 25116159
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis.
    Torka P; Hahn T; Bertolo J; Liu H; Ross M; Paplham P; Jankowski A; Deeb G; Chen G; McCarthy P
    Bone Marrow Transplant; 2015 Nov; 50(11):1480-2. PubMed ID: 26214139
    [No Abstract]   [Full Text] [Related]  

  • 8. Whole blood harvested after granulocyte-colony stimulating factor (Neupogen) mobilization, and reinfused unprocessed after high-dose melphalan treatment, accelerates hematopoietic recovery in patients with multiple myeloma.
    Raina V; Sharma A; Kumar R; Bhargava M
    Cancer; 1996 Mar; 77(6):1073-8. PubMed ID: 8635126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
    Gupta S; Zhou P; Hassoun H; Kewalramani T; Reich L; Costello S; Drake L; Klimek V; Dhodapkar M; Teruya-Feldstein J; Hedvat C; Kalakonda N; Fleisher M; Filippa D; Qin J; Nimer SD; Comenzo RL
    Bone Marrow Transplant; 2005 Mar; 35(5):441-7. PubMed ID: 15640822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bilateral vertebral artery dissection and essential thrombocythemia with JAK2 mutation.
    Verdure P; Lefaucheur R; Guegan-Massardier E; Triquenot-Bagan A; Gerardin E; Maltête D
    Rev Neurol (Paris); 2012 Jun; 168(6-7):543-4. PubMed ID: 22677324
    [No Abstract]   [Full Text] [Related]  

  • 11. JAK2 mutations and coronary ischemia.
    Lata K; Madiraju N; Levitt L
    N Engl J Med; 2010 Jul; 363(4):396-7. PubMed ID: 20660412
    [No Abstract]   [Full Text] [Related]  

  • 12. Engraftment syndrome after hematopoietic stem cell transplantation in multiple myeloma.
    Katzel JA; Mazumder A; Jagannath S; Vesole DH
    Clin Lymphoma Myeloma; 2006 Sep; 7(2):151. PubMed ID: 17026829
    [No Abstract]   [Full Text] [Related]  

  • 13. Allografting or autografting for myeloma.
    Rajkumar SV; Kyle RA
    N Engl J Med; 2007 Jun; 356(25):2646-8; author reply 2646-8. PubMed ID: 17600891
    [No Abstract]   [Full Text] [Related]  

  • 14. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I study of intravenous plerixafor following cyclophosphamide mobilization in patients with multiple myeloma.
    Krishnan AY; Wang S; Palmer JM; Tsai NC; Thomas SH; Htut M; Farol L; Forman SJ
    Leuk Lymphoma; 2014 Jan; 55(1):201-3. PubMed ID: 23573824
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness and safety of oral cryotherapy in the prevention of oral mucositis after conditioning regimens with high-dose melphalan for autologous stem cell transplantation for lymphoma and myeloma.
    Batlle M; Morgades M; Vives S; Ferrà C; Oriol A; Sancho JM; Xicoy B; Moreno M; Magallón L; Ribera JM
    Eur J Haematol; 2014 Dec; 93(6):487-91. PubMed ID: 24889275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukemic transformation in essential thrombocythemia.
    Bhatt VR
    Future Oncol; 2014 Dec; 10(16):2593-602. PubMed ID: 25531047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of autologous hematopoietic stem cell transplantation in patients with multiple myeloma and chronic renal failure.
    Tosi P; Zamagni E; Ronconi S; Benni M; Motta MR; Rizzi S; Tura S; Cavo M
    Leukemia; 2000 Jul; 14(7):1310-3. PubMed ID: 10914557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea does not appreciably reduce JAK2 V617F allele burden in patients with polycythemia vera or essential thrombocythemia.
    Antonioli E; Carobbio A; Pieri L; Pancrazzi A; Guglielmelli P; Delaini F; Ponziani V; Bartalucci N; Tozzi L; Bosi A; Rambaldi A; Barbui T; Vannucchi AM
    Haematologica; 2010 Aug; 95(8):1435-8. PubMed ID: 20418246
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic haemopoietic stem cell transplantation for multiple myeloma or plasma cell leukaemia using fractionated total body radiation and high-dose melphalan conditioning.
    Russell N; Bessell E; Stainer C; Haynes A; Das-Gupta E; Byrne J
    Acta Oncol; 2000; 39(7):837-41. PubMed ID: 11145442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.